Skip to main content
. 2020 Sep 25;20:704. doi: 10.1186/s12879-020-05399-4

Table 2.

Base case product characteristics. Simulated characteristics in parentheses

Product HIV efficacy
(bounds used in uncertainty analysis – uniform distribution)
STI efficacy Contraceptive protection Frequency of use
Oral pre-exposure prophylaxis 61% (40–75%) N (Y) N (Y) Daily
Vaginal Ring 55% (31–71%) N (Y) N (Y) Monthly
Injectable ARVs 75% (55–90%) N (Y) N (Y) Every three months
Condom 85% (66–94%) Y Y Coital
No condom 0 N N Coital